Chemical inhibitor anticancer drugs regulate mechanical properties and cytoskeletal structure of non-invasive and invasive breast cancer cell lines: Study of effects of Letrozole, Exemestane, and Everolimus
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 565, 14-20
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivoBreast Cancer Research, 2012
- Cellular Traction Stresses Increase with Increasing Metastatic PotentialPLOS ONE, 2012
- Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell LinesCancer Research, 2011
- New inhibitors of the mammalian target of rapamycin signaling pathway for cancerExpert Opinion on Investigational Drugs, 2010
- Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interactionBritish Journal of Cancer, 2010
- Aromatase Inhibitors: Are There Differences Between Steroidal and Nonsteroidal Aromatase Inhibitors and Do They Matter?The Oncologist, 2008
- The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancerBreast Cancer Research, 2008
- Autophagy delays apoptotic death in breast cancer cells following DNA damageCell Death & Differentiation, 2006
- Cell migration in tumorsCurrent Opinion in Cell Biology, 2005
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature Cell Biology, 2004